Biblio

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

G

Mura M, Lee Y-K, Pisano F, Ginevrino M, Boni M, Calabrò F, Crotti L, Valente EMaria, Schwartz PJ, Tse H-F, et al. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi005-A from a patient carrying the KCNQ1-R190W mutation. Stem Cell Res. 2019;37:101437.

Mura M, Bastaroli F, Corli M, Ginevrino M, Calabrò F, Boni M, Crotti L, Valente EMaria, Schwartz PJ, Gnecchi M. Generation of the human induced pluripotent stem cell (hiPSC) line PSMi006-A from a patient affected by an autosomal recessive form of long QT syndrome type 1. Stem Cell Res. 2019;42:101658.

Tisch M, Alemany MCarmen De, Suarez-Cubero M, Fauth C, Defrancesco M, Zschocke J, Günther K, Edenhofer F. Generation of the human induced pluripotent stem cell line (IBKMOLi002-A) from PBMCs of a patient carrying the heterozygous L271H mutation of the voltage-gated calcium channel subunit Ca1.3-encoding CACNA1D gene. Stem Cell Res. 2022;61:102784.

Wang Y-B, Lv Y-F, Zhang Y, Wang W. Generation of the human induced pluripotent stem cell line PUMCi005-A from a patient with Perrault syndrome. Stem Cell Res. 2024;75:103318.

Tan C, Dai L, Yang W, Li F, Wang L, Xiao Y, Wang X, Zhang Y, Wang Y, Zeng C, et al. Generation of the human induced pluripotent stem cell line (SHAMUi001-A) carrying the heterozygous c.-128G>T mutation in the 5'-UTR of the ANKRD26 gene. Stem Cell Res. 2020;48:102002.

Klein T, Günther K, Kwok CKeong, Edenhofer F, Üçeyler N. Generation of the human induced pluripotent stem cell line (UKWNLi001-A) from skin fibroblasts of a woman with Fabry disease carrying the X-chromosomal heterozygous c.708 G > C (W236C) missense mutation in exon 5 of the alpha-galactosidase-A gene. Stem Cell Res. 2018;31:222-226.

Klein T, Henkel L, Klug K, Kwok CKeong, Klopocki E, Üçeyler N. Generation of the human induced pluripotent stem cell line UKWNLi002-A from dermal fibroblasts of a woman with a heterozygous c.608 C>T (p.Thr203Met) mutation in exon 3 of the nerve growth factor gene potentially associated with hereditary sensory and aut. Stem Cell Res. 2018;33:171-174.

Liu B, Chen L, Sun J, Zhang L, Chen M, Qian Y, Wang Y, Yan K, Hou L, Huang Y, et al. Generation of the human induced pluripotent stem cell line (ZJUi005-A) from a patient with Pelizaeus-Merzbacher disease (PMD) carrying a novel hemizygous mutation in PLP1 gene. Stem Cell Res. 2020;45:101791.

Ko EJeong, Cui S, Shin YJin, Lim SWoo, Lee KIn, Lee JYoung, Yang CWoo, Kim M, Chung BHa. Generation of the human induced pluripotent stem cell lines (CMCi009-A) from a patient with Birt-Hogg-Dubé syndrome (BHD) with heterozygous frameshift deletion mutation c.1285delC of the FLCN gene. Stem Cell Res. 2021;51:102215.

Cañibano-Hernández A, Valdes-Sanchez L, Garcia-Delgado AB, Ponte-Zuñiga B, Díaz-Corrales FJ, De la Cerda B. Generation of the human iPSC line ESi082-A from a patient with macular dystrophy associated to mutations in the CRB1 gene. Stem Cell Res. 2021;53:102301.

Efendic F, Krohn S, Escobar HMurua, Venkateswaran S, Bennett SAL, Hermann A, Frech MJ. Generation of the human iPSC lines AKOSi011-A carrying the mutation p.Pro65Ser/p.Asp35T and AKOSi012-A, carrying the mutation p.Tyr231His, derived from FAHN patient fibroblasts. Stem Cell Res. 2023;71:103178.

Malerba N, Benzoni P, Squeo GMaria, Milanesi R, Giannetti F, Sadleir LG, Poke G, Augello B, Croce AIrma, Barbuti A, et al. Generation of the induced human pluripotent stem cell lines CSSi009-A from a patient with a GNB5 pathogenic variant, and CSSi010-A from a CRISPR/Cas9 engineered GNB5 knock-out human cell line. Stem Cell Res. 2019;40:101547.

Fukunaga I, Shiga T, Chen C, Oe Y, Danzaki K, Ohta S, Matsuoka R, Anzai T, Hibiya-Motegi R, Tajima S, et al. Generation of the induced pluripotent stem cell (hiPSC) line (JUFMDOi004-A) from a patient with hearing loss carrying GJB2 (p.V37I) mutation. Stem Cell Res. 2019;43:101674.

Claassen JN, Zhang D, Chen S-C, Moon SYoon, Lamey T, Thompson JA, McLaren T, De Roach JN, McLenachan S, Chen FK. Generation of the induced pluripotent stem cell line from a patient with autosomal recessive ABCA4-mediated Stargardt Macular Dystrophy. Stem Cell Res. 2018;34:101352.

Gridina MM, Nikitina TV, Pristyazhnyuk IE, Kashevarova AA, Lopatkina ME, Vasilyev SA, Nazarenko LP, Lebedev IN, Serov OL. Generation of the induced pluripotent stem cell line, ICAGi002-A, from unaffected carrier megabase scaled duplication involving the CNTN6 gene. Stem Cell Res. 2019;40:101556.

Kim J-H, Kang K-W, Lee B-H, Park Y, Kim B-S. Generation of the induced pluripotent stem cell line KUMi001-A carrying the Philadelphia chromosome from a chronic myeloid leukemia patient. Stem Cell Res. 2021;55:102464.

Wu H, Wang G, Gao E, Zhao J, Zhang L, Chen L, Zhu Y, Zhang J, Liu Z. Generation of the induced pluripotent stem cell line (NCKDi002-A) from a 22-year-old patient with Focal Segmental Glomerular Sclerosis carrying a heterozygous mutation in WT1 gene. Stem Cell Res. 2021;53:102293.

Wu H, Wang G, Gao E, Zhang L, Zhu Y, Zhang J, Liu Z. Generation of the induced pluripotent stem cell line (NCKDi004-A) from a 17-year-old patient with Alport syndrome carring a homozygous mutation in COL4A3 gene. Stem Cell Res. 2021;56:102557.

Qiu S, Zhang X, Zhang L, Liu Z, Wang L, Jin Z-B, Xiao P. Generation of the induced pluripotent stem cell line SFMUi001-A from a patient with usher syndrome type 2 caused by biallelic variants in the USH2A gene. Stem Cell Res. 2023;69:103101.

Ahmed E, Sansac C, Fieldes M, Bergougnoux A, Bourguignon C, Mianné J, Arnould C, Vachier I, Assou S, Bourdin A, et al. Generation of the induced pluripotent stem cell line UHOMi001-A from a patient with mutations in CCDC40 gene causing Primary Ciliary Dyskinesia (PCD). Stem Cell Res. 2018;33:15-19.

Breyer M, Klein T, Klug K, Klopocki E, Üçeyler N. Generation of the induced pluripotent stem cell line UKWNLi005-A derived from a patient with the GLA mutation c.376A > G of unknown pathogenicity in Fabry disease. Stem Cell Res. 2022;61:102747.

Calamaio S, Serzanti M, Morlino S, Massardi M, Ritelli M, Piovani G, Colombi M, Cortellini V, Castori M, Dell'Era P, et al. Generation of the induced pluripotent stem cell line UNIBSi017-A from an individual with cardiospondylocarpofacial syndrome and the MAP3K7 c.737-7A > G variant. Stem Cell Res. 2022;63:102837.

Sun X, Zhou X, Xiao X, Chi J, Dong B, Wang Y. Generation of the induced pluripotent stem cell(iPSC) line (AHQUi001-A) from a patient with familial hypertriglyceridemia (FHTG) carrying a heterozygous p.C310R (c.928 T > C) mutation in LPL gene. Stem Cell Res. 2020;45:101802.

Yu X, Wang H, Xiao F, Jiang S, Li K, Chen Q, Wang G, Kong F, Zhao S. Generation of the integration-free induced pluripotent stem cell line (FHUSTCi001-A) from a patient with glomerulopathy with fibronectin deposits harboring FN1 mutation. Stem Cell Res. 2022;61:102751.

Iannello G, Patel A, Sirabella D, Corneo B, Thaker V. Generation of the iPSC line CUIMCi003-A derived from a patient with severe early onset obesity. Stem Cell Res. 2021;54:102432.

Pages